Spruce Biosciences, Inc. (SPRBD)
OTCMKTS · Delayed Price · Currency is USD
7.00
-0.50 (-6.67%)
At close: Aug 29, 2025
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $3.94 million as of August 29, 2025. Its market cap has decreased by -77.92% in one year.
Market Cap
3.94M
Enterprise Value
-10.62M
Revenue
1.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
$7.00
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from 378.48M to 3.94M, a decrease of -98.96%. That is a compound annual growth rate of -60.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 3.94M | -77.28% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | 564.33M | 49.11% |
| Oct 9, 2020 | 378.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 837.26M |
| Elite Pharmaceuticals | 705.48M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 661.90M |
| Northwest Biotherapeutics | 443.96M |
| CytoDyn | 393.58M |
| American Oncology Network | 358.34M |